Morgan Stanley
MDXH icon

Morgan Stanley’s MDxHealth MDXH Stock Holding History

Morgan Stanley’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313 Sell
764
-15,620
-95% -$21K ﹤0.01% 7777
2026
Q1 		$37.7K Sell
16,384
-40,152
-71% -$136K ﹤0.01% 6522
2025
Q4 		$202K Buy
56,536
+51,772
+1,087% +$205K ﹤0.01% 5932
2025
Q3 		$22.2K Buy
4,764
+4,000
+524% +$12.3K ﹤0.01% 6660
2025
Q2 		$1.69K Sell
764
-2,000
-72% -$3.75K ﹤0.01% 7258
2025
Q1 		$3.92K Sell
2,764
-2,369
-46% -$4.28K ﹤0.01% 7044
2024
Q4 		$12.2K Sell
5,133
-350
-6% -$715 ﹤0.01% 6735
2024
Q3 		$11.4K Buy
5,483
+350
+7% +$950 ﹤0.01% 6677
2024
Q2 		$12.3K Hold
5,133
– – ﹤0.01% 6612
2024
Q1 		$13.3K Buy
5,133
+354
+7% +$1.24K ﹤0.01% 6599
2023
Q4 		$18.8K Hold
4,779
– – ﹤0.01% 6462
2023
Q3 		$13.4K Sell
4,779
-1,245
-21% -$4.14K ﹤0.01% 6617
2023
Q2 		$20.5K Buy
+6,024
New +$22K ﹤0.01% 6561
2022
Q1 		– Sell
-1,526
Closed -$15K – 8054
2021
Q4 		$15K Buy
+1,526
New +$15K ﹤0.01% 7322

Other funds holding MDXH

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Morgan Stanley's MDXH Position: Q2 2026 in Review

Morgan Stanley reduced its MDxHealth (MDXH) stake by 95% in Q2 2026, selling an estimated $21K and leaving 764 shares worth $313. The position accounts for ﹤0.01% of the portfolio, ranked #7777.

Morgan Stanley first reported a position in MDXH in Q4 2021 and has held it in 14 quarters since. The position peaked at $202K in Q4 2025. 26 funds tracked by Wall St. Rank hold MDXH as of Q2 2026.

  • Morgan Stanley held 764 shares of MDxHealth worth $313 as of Q2 2026.
  • Morgan Stanley sold 15,620 MDxHealth shares in Q2 2026, an estimated $21K.
  • MDxHealth made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7777 holding.
  • Morgan Stanley first reported a position in MDxHealth in Q4 2021 and has held it in 14 quarters since.
  • Morgan Stanley's MDxHealth position peaked at $202K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MDxHealth as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.